Reduced E-cadherin expression is associated with lymph node metastases in laryngeal squamous cell carcinoma

Auris Nasus Larynx

Volumn 39, Issue 2, 2012, Pages 186-192

  Li, Jing jia ^a   Zhang, Ge hua ^a   Yang, Xin ming ^b   Li, Shi sheng ^b   Liu, Xian ^a   Yang, Qin tai ^a   Li, Yuan ^a   Ye, Jin ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

E cadherin; Larynx; Metastases; Prognosis; Squamous cell carcinoma

Indexed keywords

UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER TISSUE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LARYNX CARCINOMA; LARYNX SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

AGED; CADHERINS; CARCINOMA, SQUAMOUS CELL; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LARYNX; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM STAGING; REFERENCE VALUES; RETROSPECTIVE STUDIES;

EID: 84856722409     PISSN: 03858146     EISSN: 18791476     Source Type: Journal    
DOI: 10.1016/j.anl.2011.04.003     Document Type: Article

References (30)

1. Sanderson R.J., Ironside J.A. Squamous cell carcinomas of the head and neck. BMJ 2002, 325:822-827.
2. Karatzanis A.D., Psychogios G., Zenk J., Waldfahrer F., Hornung J., Velegrakis G.A., et al. Comparison among different available surgical approaches in T1 glottic cancer. Laryngoscope 2009, 119:1704-1708.
3. Cosetti M., Yu G.P., Schantz S.P. Five-year survival rates and time trends of laryngeal cancer in the US population. Arch Otolaryngol Head Neck Surg 2008, 134:370-379.
4. Geiger T.R., Peeper D.S. Metastasis mechanisms. Biochim Biophys Acta 2009, 1796:293-308.
5. Makrilia N., Kollias A., Manolopoulos L., Syrigos K. Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest 2009, 27:1023-1037.
6. Shapiro L., Weis W.I. Structure and biochemistry of cadherins and catenins. Cold Spring Harb Perspect Biol 2009, 1:a003053.
7. Hajra K.M., Fearon E.R., Cadherin catenin alterations in human cancer. Genes Chromosomes Cancer 2002, 34:255-268.
8. Mǎrgineanu E., Cotrutz C.E., Cotrutz C. Correlation between E-cadherin abnormal expressions in different types of cancer and the process of metastasis. Rev Med Chir Soc Med Nat Iasi 2008, 112:432-436.
9. Rodrigo J.P., Domínquez F., Suárez V., Canel M., Secades P., Chiara M.D. Focal adhesion kinase and E-cadherin as markers for nodal metastasis in laryngeal cancer. Arch Otolaryngol Head Neck Surg 2007, 133:145-150.
10. Rodríquez Tojo M.J., García Cano F.J., Infante Sánchez J.C., Velázquez Fernández E., Aguirre Urízar J.M. Immunoexpression of p53 Ki-67 and E-cadherin in basaloid squamous cell carcinomas of the larynx. Clin Transl Oncol 2005, 7:110-114.
11. Rodrigo J.P., Domínguez F., Alvarez C., Manrique C., Herrero A., Suárez C. Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features. Eur J Cancer 2002, 38:1059-1064.
12. Rodrigo Tapia J.P., Domínquez Iqlesias F., Alvarez Marcos C., González Meana M.V., García Pedrero J., Suárez Nieto C. Prognostic significance of the expression of adhesion molecules E-cadherin Cd44 and CD44V6 in supraglottic squamous carcinoma. Acta Otorrinolaringol Esp 2002, 53:745-751.
13. Andrews N.A., Jones A.S., Helliwell T.R., Kinsella A.R. Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br J Cancer 1997, 75:1474-1480.
14. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96.
15. Snow G.B., Patel P., Leemans C.R., Tiwari R. Management of cervical lymph nodes in patients with head and neck cancer. Eur Arch Otorhinolaryngol 1992, 249:187-194.
16. Lutz C.K., Johnson J.T., Wagner R.L., Myers E.N. Supraglottic carcinoma: patterns of recurrence. Ann Otol Rhinol Laryngol 1990, 99:12-17.
17. Oztürkcan S., Katilmiş H., Ozdemir I., Tuna B., Güvenç I.A., Dündar R. Occult contralateral nodal metastases in supraglottic laryngeal cancer crossing the midline. Eur Arch Otorhinolaryngol 2009, 266:117-120.
18. Muller S., Su L., Tighiouart M., Saba N., Zhang H., Shin D.M., et al. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation. Cancer 2008, 113:97-107.
19. Van Den Brekel M.W., Castelijns J.A., Stel H.V., Golding R.P., Meyer C.J., Snow G.B. Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol 1993, 250:11-17.
20. Van Den Brekel M.W.M., Castelijns J.A., Snow G.B. Diagnostic evaluation of the neck. Otolaryngol Clin North Am 1998, 31:601-620.
21. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998, 153:333-339.
22. Schmalhofer O., Brabletz S., Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 2009, 28:151-166.
23. Ghaffari S.R., Dastan J., Rafati M., Sabokbar T. Novel human pathological mutations Gene symbol: CDH1. Disease: gastric cancer. Hum Genet 2009, 125:337.
24. Masciari S., Larsson N., Senz J., Boyd N., Kaurah P., Kandel M.J., et al. Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet 2007, 44:726-731.
25. Droufakou S., Deshmane V., Roylance R., Hanby A., Tomlinson I., Hart I.R. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int J Cancer 2001, 92:404-408.
26. Kwon G.Y., Yoo B.C., Koh K.C., Cho J.W., Park W.S., Park C.K. Promoter methylation of E-cadherin in hepatocellular carcinomas and dysplastic nodules. J Korean Med Sci 2005, 20:242-247.
27. Shvero J., Hader T., Feinmesser R., Har-El G., Martin D., Marshak G., et al. Laryngeal carcinoma in females. Eur J Surg Oncol 1996, 22:61-64.
28. Stell P.M. Prognosis in laryngeal carcinoma: host factors. Clin Otolaryngol 1990, 15:111-119.
29. Nguyen-Tan P.F., Le Q.T., Quivey J.M., Singer M., Terris D.J., Goffinet D.R., et al. Treatment results and prognostic factors of advanced T3-4 laryngeal carcinoma: the University of California San Francisco (UCSF) and Stanford University Hospital (SUH) experience. Int J Radiat Oncol Biol Phys 2001, 50:1172-1180.
30. Cabanillas R., Rodrigo J.P., Astudillo A., Domínguez F., Suárez C., Chiara M.D. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question. Cancer 2007, 109:1791-1798.